These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 16023817
21. High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans. Yun MH, Kwon KI. J Pharm Biomed Anal; 2006 Jan 23; 40(1):168-72. PubMed ID: 16095861 [Abstract] [Full Text] [Related]
22. Isolation and structural confirmation of N-desmethyl topotecan, a metabolite of topotecan. Rosing H, Herben VM, van Gortel-van Zomeren DM, Hop E, Kettenes-van den Bosch JJ, ten Bokkel Huinink WW, Beijnen JH. Cancer Chemother Pharmacol; 1997 Jan 23; 39(6):498-504. PubMed ID: 9118461 [Abstract] [Full Text] [Related]
23. High-performance liquid chromatographic assay for the determination of total and free topotecan in the presence and absence of anti-topotecan antibodies in mouse plasma. Chen J, Balthasar JP. J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb 25; 816(1-2):183-92. PubMed ID: 15664349 [Abstract] [Full Text] [Related]
24. High-performance liquid chromatographic assay for glucuronidation activity of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes. Hanioka N, Jinno H, Nishimura T, Ando M, Ozawa S, Sawada J. Biomed Chromatogr; 2001 Aug 25; 15(5):328-33. PubMed ID: 11507714 [Abstract] [Full Text] [Related]
25. Application of an acceptance sampling plan for post-production quality control of chemotherapeutic batches in an hospital pharmacy. Borget I, Laville I, Paci A, Michiels S, Mercier L, Desmaris RP, Bourget P. Eur J Pharm Biopharm; 2006 Aug 25; 64(1):92-8. PubMed ID: 16750352 [Abstract] [Full Text] [Related]
26. Development and validation of a liquid chromatography-tandem mass spectrometry method for topotecan determination in beagle dog plasma and its application in a bioequivalence study. Ye L, Shi J, Wan S, Yang X, Wang Y, Zhang J, Zheng D, Liu Z. Biomed Chromatogr; 2013 Nov 25; 27(11):1532-9. PubMed ID: 23788247 [Abstract] [Full Text] [Related]
27. Determination of camptothecin analogs in biological matrices by high-performance liquid chromatography. Loos WJ, de Bruijn P, Verweij J, Sparreboom A. Anticancer Drugs; 2000 Jun 25; 11(5):315-24. PubMed ID: 10912947 [Abstract] [Full Text] [Related]
28. Determination of the active ingredient loperamide hydrochloride in pharmaceutical caplets by high performance thin layer chromatography with ultraviolet absorption densitometry of fluorescence quenched zones. Ruddy DA, Sherma J. Acta Pol Pharm; 2002 Jun 25; 59(1):15-8. PubMed ID: 12026106 [Abstract] [Full Text] [Related]
29. A simple HPLC method with fluorescence detection for simultaneous determination of 10-methoxycamptothecin and its metabolite 10-hydroxycamptothecin in rat liver tissue. Liu Y, Shao C, Fan B, Li S, Wang Y, Zheng J. Drug Res (Stuttg); 2015 Mar 25; 65(3):147-52. PubMed ID: 24782285 [Abstract] [Full Text] [Related]
30. Determination of leflunomide in tablets by high performance liquid chromatography. Yeniceli D, Dogrukol-Ak D, Tuncel M. J Pharm Biomed Anal; 2006 Jan 23; 40(1):197-201. PubMed ID: 16112831 [Abstract] [Full Text] [Related]
31. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. Burke TG, Mi Z. J Med Chem; 1994 Jan 07; 37(1):40-6. PubMed ID: 8289200 [Abstract] [Full Text] [Related]
32. Determination of topotecan in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography. de Vries NA, Ouwehand M, Buckle T, Beijnen JH, van Tellingen O. Biomed Chromatogr; 2007 Nov 07; 21(11):1191-200. PubMed ID: 17582233 [Abstract] [Full Text] [Related]
33. Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles. Martins SM, Wendling T, Gonçalves VM, Sarmento B, Ferreira DC. J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan 01; 880(1):100-7. PubMed ID: 22153332 [Abstract] [Full Text] [Related]
34. Forced degradation and impurity profiling: recent trends in analytical perspectives. Jain D, Basniwal PK. J Pharm Biomed Anal; 2013 Dec 01; 86():11-35. PubMed ID: 23969330 [Abstract] [Full Text] [Related]
35. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation. Mostafavi A, Abedi G, Jamshidi A, Afzali D, Talebi M. Talanta; 2009 Feb 15; 77(4):1415-9. PubMed ID: 19084658 [Abstract] [Full Text] [Related]
36. Validation of a high-performance thin-layer chromatography/densitometry method for the quantitative determination of glucosamine in a herbal dietary supplement. Esters V, Angenot L, Brandt V, Frédérich M, Tits M, Van Nerum C, Wauters JN, Hubert P. J Chromatogr A; 2006 Apr 21; 1112(1-2):156-64. PubMed ID: 16472532 [Abstract] [Full Text] [Related]
37. A validated HPLC stability-indicating method for the determination of diacerhein in bulk drug substance. Giannellini V, Salvatore F, Bartolucci G, Coran SA, Bambagiotti-Alberti M. J Pharm Biomed Anal; 2005 Sep 15; 39(3-4):776-80. PubMed ID: 15955656 [Abstract] [Full Text] [Related]
38. Chemical fingerprinting of Equisetum arvense L. using HPTLC densitometry and HPLC. Gallo FR, Multari G, Federici E, Palazzino G, Giambenedetti M, Petitto V, Poli F, Nicoletti M. Nat Prod Res; 2011 Aug 15; 25(13):1261-70. PubMed ID: 21854173 [Abstract] [Full Text] [Related]